Seeking Alpha

MNTA
Momenta Pharmaceuticals, Inc.

5/26/2012, 4:55 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MNTA Market Currents more »
  • May 3 Momenta Pharmaceuticals (MNTA): Q1 EPS of -$0.10 may not be comparable to consensus of $0.02. Revenue of $24.2M (-69% Y/Y) misses by $13M. (PR)
    Comment!
    [Earnings, Healthcare]
MNTA in Focus more »
MNTA Instablog posts more »
  • Magic Formula Investing Weekly Roundup 3/18/2012
    Sun, Mar 18 • MagicDiligence • Comment!
  • Magic Formula Investing Weekly Roundup 12/5/2011
    Mon, Dec 5, 2011 • MagicDiligence • Comment!
  • Magic Formula Investing Weekly Roundup 11/13/2011
    Sun, Nov 13, 2011 • MagicDiligence • Comment!
  • Four Beaten-down Biotech Stocks that are on my BUY list
    Tue, Aug 23, 2011 • bioduediligence • Comment!
  • Magic Formula Investing Weekly Roundup 8/14/2011
    Sun, Aug 14, 2011 • MagicDiligence • Comment!
Write a post on MNTA
MNTA StockTalks
MNTA vs. ETF Alternatives
Company Description

Momenta is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, like heparan-sulfate proteoglycans, or HSPGs. This results in a diversified product... More

Sector: Healthcare
Industry: Biotechnology
Country: United States